Webinars
Key Considerations for Dosage Regimen Patents at the EPO
In this inaugural episode of the SLW Chemistry and Biology Webinar Series, guest speakers Charlotte Watkins and Hazel Robson of Secerna LLP present on dosage regimens from a small molecule and alternatively a biological molecule perspective and identify potential divergent approaches from the EPO. SLW’s Nicholas Lanzatella moderates the event.
Charlotte Watkins is a Chartered Patent Attorney in the UK, a European Patent Attorney and a UPC Representative. A founding partner at Secerna, she has practiced in the field of Intellectual Property since 2001, working primarily in the life sciences sector. She also has wide experience in patent enforcement and defense globally. As well as being highly experienced before the UK Intellectual Property Office and European Patent Office, Charlotte has a notable knowledge of the patent systems of many other key jurisdictions.
Hazel Robson is a senior associate at Secerna. A Chartered Patent Attorney in the UK and a European Patent Attorney, Hazel Robson is an accomplished intellectual property attorney with a deep understanding of the pharmaceutical and chemical landscapes. Her expertise spans a broad range of pharmaceutical IP, encompassing new chemical entities, polymorphs, formulations, manufacturing processes, and medical devices. With a strong foundation gained from supporting drug discovery, development, and clinical trials at a global pharmaceutical company, Hazel brings a wealth of industry knowledge and strategic acumen to her work.